How is Novartis Capitalizing on AI for Medical Innovations?

Artificial intelligence is nothing strange now, as it is being used by almost all businesses in different industries. The rapid digital transformation and technology adoption in recent years has led many companies to extensively invest in AI to drive growth. Novartis International AG is a leading global healthcare company, based out of Switzerland, that has been efficiently capitalizing on its AI capabilities to develop medical innovations. Novartis incorporates digital and disruptive technologies to create transformative treatment and drug discoveries. Everybody is trying to adopt AI, but how many focus on an ethical approach?